Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | PKM | P14618 | 2/20 | 0.49 |
| ▸ | BRD4 | O60885 | 1/20 | 0.48 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
| ▸ | BCR | P11274 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.42 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | FGFR4 | P22455 | 3/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30955697 | 0.86 | CYP2C19 (0.58) | L3MBTL1PKMBRD4ABL1BCR | |
| SCHEMBL29229341 | 0.86 | CYP2C19 (0.58) | L3MBTL1PKMBRD4ABL1BCR | |
| SCHEMBL31052371 | 0.83 | L3MBTL1 (0.59) | L3MBTL1PKMBRD4CYP2C19POLB | |
| SCHEMBL31052347 | 0.81 | L3MBTL1 (0.56) | L3MBTL1PKMBRD4CYP2C19POLB | |
| SCHEMBL29721737 | 0.80 | L3MBTL1 (0.62) | L3MBTL1PKMBRD4CYP2C19POLB | |
| SCHEMBL14735293 | 0.80 | L3MBTL1 (0.62) | L3MBTL1PKMBRD4CYP2C19POLB | |
| SCHEMBL14487894 | 0.80 | L3MBTL1 (0.61) | L3MBTL1PKMBRD4ABL1BCR | |
| SCHEMBL27902479 | 0.80 | HTT (0.53) | L3MBTL1ABL1BCRPOLBALDH3A1 | |
| SCHEMBL2241097 | 0.79 | L3MBTL1 (0.64) | L3MBTL1PKMBRD4CYP2C19POLB | |
| SCHEMBL19020570 | 0.78 | L3MBTL1 (0.52) | L3MBTL1PKMBRD4ABL1BCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109608468-B | Tofacitinib citrate impurity, and synthesis method and application thereof | 成都倍特药业股份有限公司 | 2020-09-29 | — | — | CN | disclosed |
| CN-109608468-A | Tofacitinib citrate impurity, and synthesis method and application thereof | 成都倍特药业有限公司 | 2019-04-12 | — | — | CN | disclosed |
| CN-102711473-B | Bruton's tyrosine kinase inhibitors | 比奥根MA公司 | 2016-11-09 | — | — | CN | disclosed |
| WO-2016100349-A2 | BICYCLIC AZAHETEROCYCLIC COMPOUNDS AS NR2B NMDA RECEPTOR ANTAGONISTS | RUGEN HOLDINGS (CAYMAN) LIMITED (KY) | 2016-06-23 | — | — | WO | disclosed |
| WO-2016100349-A2 | BICYCLIC AZAHETEROCYCLIC COMPOUNDS AS NR2B NMDA RECEPTOR ANTAGONISTS | RUGEN HOLDINGS (CAYMAN) LIMITED (KY) | 2016-06-23 | — | — | WO | disclosed |